期刊文献+

平均血小板聚集率水平对药物支架置入术后长期双联抗血小板治疗冠心病患者预后的影响 被引量:18

Relationship between the mean platelet aggregation degree and the prognosis of patients underwent long-term dual antiplatelet therapy following drug eluting stent implantation
原文传递
导出
摘要 目的 探讨在药物洗脱支架置入术后长期(超过12个月)双联抗血小板治疗的冠心病患者中,氯吡格雷药效对其预后的影响.方法 回顾性分析2006年9月至2009年6月在北京安贞医院置入药物洗脱支架的752例冠心病患者,在整个双联抗血小板治疗期间通过多次测定二磷酸腺苷(ADP)介导的血小板聚集率检测氯吡格雷对血小板的抑制程度,计算患者血小板聚集率的平均水平.根据血小板聚集率的平均水平分为低ADP水平组(374例)和高ADP水平组(378例),随访时间为32.2(25.1,34.8)个月,比较2组患者的复合终点(包括全因死亡、非致死性心肌梗死、支架血栓、再次血运重建和卒中)发生率的差异.结果 与高ADP水平组患者相比,低ADP水平组患者多为男性,年龄较轻,且吸烟构成比较大(P均<0.05).单因素COX分析显示低ADP水平是复合终点的保护因素(HR =0.463,95% CI 0.23 ~0.92,P=0.028),多因素COX分析显示该相关性独立于其他危险因素(HR =0.495,95% CI 0.25 ~0.99,P=0.046).Kaplan-Meier曲线示高ADP水平组复合终点发生率高于低ADP水平组(log-rank x2=5.042,P=0.025).结论 长期双联抗血小板治疗冠心病患者的预后与二磷酸腺苷介导的平均血小板聚集率水平有一定的相关性. Objective To evaluate the association between the mean platelet aggregation degreeand the prognosis of patients underwent long-term dual antiplatelet therapy (DAPT more than 12 months) following drug eluting stent (DES) implantation.Methods A total of 752 patients were retrospectively analyzed who were received DES between September 2006 and June 2009.Adenosine diphosphate-induced platelet aggregation (ADP) was monitored during the course of treatment with DAPT,and the mean platelet aggregation degree of each participant was calculated.Based on the mean platelet aggregation degree,patients were divided into the low ADP degree group (374 cases) and the high ADP degree group (378 cases).The median follow-up period was 32.2 (25.1,34.8) months.The comparison of the composite endpoints (all-cause death,nonfatal myocardial infarction,stent thrombosis,repeat revascularization and stroke) was performed between the two groups.Results Compared with the high ADP degree group,there were more male,younger and smoker patients in the low ADP degree group (all P 〈 0.05).COX regression analysis showed that the low ADP degree group was associated with a decreased incidence of primary endpoints (HR =0.463,95% CI 0.23-0.92,P =0.028).After adjustment with multivariable COX regression analysis,the relationship was proven to be independent of other risk factors (HR =0.495,95% CI 0.25-0.99,P =0.046).The Kaplan-Meier curve demonstrated the incidence of the composite endpoints was significantly higher in high ADP degree group compared to that of low ADP degree group (log-rank x2 =5.042,P =0.025).Conclusion The mean adenosine diphosphate-induced platelet aggregation degree is associated with the prognosis of patients underwent long term DAPT after DES implantation.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2016年第2期133-137,共5页 Chinese Journal of Cardiology
基金 基金项目:首都医学发展科研基金(2009-2074) 北京市医院管理局临床医学发展专项经费(XMLM201406)
关键词 冠状动脉疾病 血小板聚集抑制剂 预后 Coronary disease Platelet aggregation inhibitors Prognosis
  • 相关文献

参考文献19

  • 1Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization[J]. Eur Heart J, 2010, 31(20): 2501-2555. DOI : 10. 1093/eurheartj/ehq277.
  • 2Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/ AHA/SCAI Guideline for Pereutaneous Coronary Intervention: executive summary : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[ J ]. Circulation, 2011, 124 (23): 2574-2609. DOI: 10. 1161/CIR. 0b013e31823a5596.
  • 3Park SJ, Park DW, Kim YH, et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents [ J ]. N Engl J Med, 2010, 362 (15): 1374-1382. DOI: 10. 1056/ NEJMoal001266.
  • 4Valgimigli M, Campo G, Monti M, et al. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized muhicenter trial [ J]. Circulation, 2012, 125 (16) : 2015-2026. DOI : 10.1161/CIRCULATIONAHA. 111.071589.
  • 5Mulukutla SR, Marroquin OC, Vlachos HA, et al. Benefit of long-term dual anti-platelet therapy in patients treated with drug- eluting stents: from the NHLBI dynamic registry [ J ]. Am J Cardiol, 2013, 111 (4) : 486-492. DOI: 10. 1016/j. amjcard. 2012.10. 030.
  • 6Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity [ J ]. Circulation, 2003, 107 (23) : 2908-2913. DOI : 10.1161/01. CIR. 0000072771.11429.83.
  • 7Sofi F, Marcucci R, Gori AM, et al. Clopidogrel non- responsiveness and risk of cardiovascular morbidity. An updated meta-analysis[ J ]. Thromb Haemost, 2010, 103 (4) : 841-848. DOI : 10. 1160/TH09-06-0418.
  • 8Madsen EH, Saw J, Kristensen SR, et al. Long-term aspirin and clopidogrel response evaluated by light transmission aggregometry, VerifyNow, and thrombelastography in patients undergoing percutaneous coronary intervention [ J]. Clin Chem, 2010, 56 (5) : 839-847. DOI:10.1373/clinchem. 2009. 137471.
  • 9Parodi G, Marcucci R, Valenti R, et al. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI[ J ]. JAMA, 2011, 306 ( 11 ) : 1215-1223. DOI: 10. 1001/ jama. 2011. 1332.
  • 10Price MJ, Angiolillo DJ, Teirstein PS, et al. Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention : a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: impact on thrombosis and safety (GRAVITAS) trial[ J]. Circulation, 2011, 124(10) : 1132-1137. DOI: 10.1161/CIRCULATIONAHA. 111. 029165.

二级参考文献1

  • 1Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol, 2007, 50 : 2173-2195.

共引文献185

同被引文献189

  • 1晋章明,余志杰.冠心病合并房颤抗凝与双联抗血小板治疗的效果比较[J].血栓与止血学,2019,25(1):60-62. 被引量:15
  • 2Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents [J]. N Engl J Med, 2013, 368(3): 254-265. DOI:10.1056/ NEJMral210816.
  • 3Li S, Wu Y, Du X, et al. Rational and design of a stepped-wedge cluster randomized trial evaluating quality improvement initiative for reducing cardiovascular events among patients with acute coronary syndromes in resource-constrained hospitals in China [J]. Am Heart J, 2015, 169 (3): 349-355. DOI:10.1016/ j. ahj. 2014. 12. 005.
  • 4Gibson CM, Murphy SA, Kirtane AJ, et al. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction[ J]. J Am Coil Cardiol, 2004, 44 (5) : 980-987. DOI:10. 1016/j. jacc. 2004.05. 059.
  • 5Collen D, Stassen JM, Verstraete M. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration [J]. J Clin Invest, 1983, 71(2) : 368-376.
  • 6Huber K. Plasminogen activator inhibitor type-1 ( part two) : role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents [ J ]. J Thromb Thrombolysis, 2001, 11(3): 195-202.
  • 7Schomig A, Ndrepepa G,Kastrati A. Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction [ J ]. Eur Heart J, 2006,27 ( 16 ) : 1900- 1907. DOI : 10. 1093/eurheartj/ehl174.
  • 8Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J] . Eur Heart J, 2012, 33 (20) : 2569-2619. DOI:10. 1093/eurheartj/ehs215.
  • 9O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infaretion: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2013, 61 (4) : e78-e140. DOI:10. 1016/j. jacc. 2012. 11. 019.
  • 10Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes[ Jl. N Engl J Med, 2009, 361 (11): 1045-1057. DOI: 10.1056/ NEJMoa0904327.

引证文献18

二级引证文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部